BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36902378)

  • 1. Data-Driven Radiogenomic Approach for Deciphering Molecular Mechanisms Underlying Imaging Phenotypes in Lung Adenocarcinoma: A Pilot Study.
    Fischer S; Spath N; Hamed M
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of radiogenomics in esophageal cancer on clinical outcomes: A pilot study.
    Brancato V; Garbino N; Mannelli L; Aiello M; Salvatore M; Franzese M; Cavaliere C
    World J Gastroenterol; 2021 Sep; 27(36):6110-6127. PubMed ID: 34629823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Small Cell Lung Cancer Radiogenomics Map Identifies Relationships between Molecular and Imaging Phenotypes with Prognostic Implications.
    Zhou M; Leung A; Echegaray S; Gentles A; Shrager JB; Jensen KC; Berry GJ; Plevritis SK; Rubin DL; Napel S; Gevaert O
    Radiology; 2018 Jan; 286(1):307-315. PubMed ID: 28727543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling.
    Yeh AC; Li H; Zhu Y; Zhang J; Khramtsova G; Drukker K; Edwards A; McGregor S; Yoshimatsu T; Zheng Y; Niu Q; Abe H; Mueller J; Conzen S; Ji Y; Giger ML; Olopade OI
    Cancer Imaging; 2019 Jul; 19(1):48. PubMed ID: 31307537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering Genomic Underpinnings of Quantitative MRI-based Radiomic Phenotypes of Invasive Breast Carcinoma.
    Zhu Y; Li H; Guo W; Drukker K; Lan L; Giger ML; Ji Y
    Sci Rep; 2015 Dec; 5():17787. PubMed ID: 26639025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular profiles of tumor contrast enhancement: A radiogenomic analysis in anaplastic gliomas.
    Liu X; Li Y; Sun Z; Li S; Wang K; Fan X; Liu Y; Wang L; Wang Y; Jiang T
    Cancer Med; 2018 Sep; 7(9):4273-4283. PubMed ID: 30117304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiogenomic association of deep MR imaging features with genomic profiles and clinical characteristics in breast cancer.
    Liu Q; Hu P
    Biomark Res; 2023 Jan; 11(1):9. PubMed ID: 36694221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models.
    Zinn PO; Singh SK; Kotrotsou A; Hassan I; Thomas G; Luedi MM; Elakkad A; Elshafeey N; Idris T; Mosley J; Gumin J; Fuller GN; de Groot JF; Baladandayuthapani V; Sulman EP; Kumar AJ; Sawaya R; Lang FF; Piwnica-Worms D; Colen RR
    Clin Cancer Res; 2018 Dec; 24(24):6288-6299. PubMed ID: 30054278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features.
    Gevaert O; Mitchell LA; Achrol AS; Xu J; Echegaray S; Steinberg GK; Cheshier SH; Napel S; Zaharchuk G; Plevritis SK
    Radiology; 2014 Oct; 273(1):168-74. PubMed ID: 24827998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomics and gene expression profile to characterise the disease and predict outcome in patients with lung cancer.
    Kirienko M; Sollini M; Corbetta M; Voulaz E; Gozzi N; Interlenghi M; Gallivanone F; Castiglioni I; Asselta R; Duga S; Soldà G; Chiti A
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3643-3655. PubMed ID: 33959797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Illuminating radiogenomic characteristics of glioblastoma multiforme through integration of MR imaging, messenger RNA expression, and DNA copy number variation.
    Jamshidi N; Diehn M; Bredel M; Kuo MD
    Radiology; 2014 Jan; 270(1):1-2. PubMed ID: 24056404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiogenomics in Clear Cell Renal Cell Carcinoma: Correlations Between Advanced CT Imaging (Texture Analysis) and MicroRNAs Expression.
    Marigliano C; Badia S; Bellini D; Rengo M; Caruso D; Tito C; Miglietta S; Palleschi G; Pastore AL; Carbone A; Fazi F; Petrozza V; Laghi A
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819878458. PubMed ID: 31564221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a radiogenomic association map of pancreatic ductal adenocarcinoma.
    Jamshidi N; Senthilvelan J; Dawson DW; Donahue TR; Kuo MD
    BMC Cancer; 2023 Feb; 23(1):189. PubMed ID: 36843111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles.
    Yerukala Sathipati S; Ho SY
    Sci Rep; 2017 Aug; 7(1):7507. PubMed ID: 28790336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiogenomic Signatures of Oncotype DX Recurrence Score Enable Prediction of Survival in Estrogen Receptor-Positive Breast Cancer: A Multicohort Study.
    Fan M; Cui Y; You C; Liu L; Gu Y; Peng W; Bai Q; Gao X; Li L
    Radiology; 2022 Mar; 302(3):516-524. PubMed ID: 34846204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a radiomic biomarker with volumetric analysis for decoding tumour phenotypes of lung adenocarcinoma with different disease-specific survival.
    Yuan M; Zhang YD; Pu XH; Zhong Y; Li H; Wu JF; Yu TF
    Eur Radiol; 2017 Nov; 27(11):4857-4865. PubMed ID: 28523350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer.
    Rios Velazquez E; Parmar C; Liu Y; Coroller TP; Cruz G; Stringfield O; Ye Z; Makrigiorgos M; Fennessy F; Mak RH; Gillies R; Quackenbush J; Aerts HJWL
    Cancer Res; 2017 Jul; 77(14):3922-3930. PubMed ID: 28566328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiogenomic Analysis of Papillary Thyroid Carcinoma for Prediction of Cervical Lymph Node Metastasis: A Preliminary Study.
    Tong Y; Sun P; Yong J; Zhang H; Huang Y; Guo Y; Yu J; Zhou S; Wang Y; Wang Y; Ji Q; Wang Y; Chang C
    Front Oncol; 2021; 11():682998. PubMed ID: 34268116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer.
    Jiang L; You C; Xiao Y; Wang H; Su GH; Xia BQ; Zheng RC; Zhang DD; Jiang YZ; Gu YJ; Shao ZM
    Cell Rep Med; 2022 Jul; 3(7):100694. PubMed ID: 35858585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiogenomic analysis of breast cancer using MRI: a preliminary study to define the landscape.
    Yamamoto S; Maki DD; Korn RL; Kuo MD
    AJR Am J Roentgenol; 2012 Sep; 199(3):654-63. PubMed ID: 22915408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.